OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
August 02, 2008
FDA is modernizing adverse-event reporting as part of a revolution in drug-safety assessment.
July 02, 2008
New scientific discoveries promise to expand treatments for rare and neglected diseases.
June 02, 2008
Comparative-effectiveness analysis aims to promote appropriate pharmaceutical spending.
May 02, 2008
Regulators face demands to improve postmarket surveillance and meet review deadlines.
April 02, 2008
Heparin contamination casts a shadow on regulatory oversight of product quality.
March 13, 2008
Much to the surprise of most close observers of the Food and Drug Administration, Janet Woodcock agreed last month to resume control of the Center for Drug Evaluation and Research.